Sana Biotechnology, Inc. - Common Stock (SANA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
SANA on Nasdaq
Shares outstanding
267,515,765
Price per share
$4.58
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
65,601,752
Total reported value
$267,018,439
% of total 13F portfolios
0%
Share change
+1,317,699
Value change
+$5,582,891
Number of holders
137
Price from insider filings
$4.58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Sana Biotechnology, Inc. - Common Stock (SANA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARCH Venture Fund IX, L.P. 17% $163,630,594 46,093,125 Robert Nelsen 30 Sep 2025
BlackRock, Inc. 5.1% +4% $55,528,247 +$10,647,588 13,643,304 +24% BlackRock, Inc. 31 Dec 2025
VANGUARD GROUP INC 4.8% $19,023,535 10,747,760 The Vanguard Group 31 Dec 2024

As of 31 Dec 2025, 137 institutional investors reported holding 65,601,752 shares of Sana Biotechnology, Inc. - Common Stock (SANA). This represents 25% of the company’s total 267,515,765 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Sana Biotechnology, Inc. - Common Stock (SANA) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 5.3% 14,223,527 +27% 0% $57,889,754
VANGUARD GROUP INC 3.9% 10,455,195 +15% 0% $42,552,645
STATE STREET CORP 3% 8,054,841 +21% 0% $32,783,203
BAILLIE GIFFORD & CO 2.5% 6,609,065 -42% 0.02% $26,898,895
GEODE CAPITAL MANAGEMENT, LLC 1.5% 4,118,138 +20% 0% $16,763,171
Marex Group plc 1.4% 3,732,780 -2.4% 0.16% $15,192,415
Alphabet Inc. 1.1% 2,812,500 0% 0.44% $11,446,875
RENAISSANCE TECHNOLOGIES LLC 0.63% 1,691,116 -15% 0.01% $6,882,842
GOLDMAN SACHS GROUP INC 0.56% 1,488,377 +118% 0% $6,057,694
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.52% 1,399,335 +10% 0% $5,695,293
MORGAN STANLEY 0.48% 1,285,045 +47% 0% $5,230,133
UBS Group AG 0.44% 1,182,958 -18% 0% $4,814,639
JPMORGAN CHASE & CO 0.3% 815,455 -62% 0% $3,318,902
JANE STREET GROUP, LLC 0.25% 668,884 +190% 0% $2,722,358
DEUTSCHE BANK AG\ 0.21% 562,312 +3.5% 0% $2,288,610
BARCLAYS PLC 0.19% 509,889 -3% 0% $2,075,249
Bank of New York Mellon Corp 0.17% 457,226 +13% 0% $1,860,912
Swiss National Bank 0.13% 335,800 +28% 0% $1,366,706
Squarepoint Ops LLC 0.12% 331,741 +49% 0% $1,350,186
Nuveen, LLC 0.12% 325,212 +7% 0% $1,323,613
Rafferty Asset Management, LLC 0.1% 274,162 +2.3% 0% $1,115,839
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.09% 240,414 +71% 0% $978,485
IEQ CAPITAL, LLC 0.09% 236,692 -1.3% 0% $963,336
WELLS FARGO & COMPANY/MN 0.07% 191,081 +80% 0% $777,700
RHUMBLINE ADVISERS 0.07% 189,412 -3.2% 0% $770,895

Institutional Holders of Sana Biotechnology, Inc. - Common Stock (SANA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 65,601,752 $267,018,439 +$5,582,891 $4.07 137
2025 Q3 163,611,333 $580,833,656 +$66,171,326 $3.55 176
2025 Q2 145,417,350 $397,022,759 -$12,602,331 $2.73 152
2025 Q1 149,116,670 $250,510,959 -$14,520,086 $1.68 156
2024 Q4 157,928,176 $257,417,788 -$2,121,232 $1.63 159
2024 Q3 153,260,123 $637,634,346 +$16,640,858 $4.16 150
2024 Q2 148,167,660 $809,021,070 +$44,986 $5.46 144
2024 Q1 146,274,865 $1,462,752,586 +$233,741,262 $10.00 151
2023 Q4 124,526,898 $508,113,977 -$12,215,240 $4.08 128
2023 Q3 127,513,989 $493,495,510 -$30,211,194 $3.87 132
2023 Q2 134,904,538 $804,023,148 +$26,527,612 $5.96 121
2023 Q1 130,716,654 $427,414,965 +$6,519,444 $3.27 118
2022 Q4 128,403,041 $507,152,945 -$769,516 $3.95 119
2022 Q3 128,339,963 $769,886,255 +$13,983,486 $6.00 122
2022 Q2 125,590,881 $807,500,039 +$40,235,857 $6.43 111
2022 Q1 119,405,403 $985,831,531 +$36,653,787 $8.26 109
2021 Q4 111,562,858 $1,727,117,718 +$20,231,159 $15.48 101
2021 Q3 75,725,736 $1,706,389,522 +$266,392,448 $22.52 85
2021 Q2 64,059,346 $1,259,281,145 +$104,914,051 $19.66 78
2021 Q1 58,277,829 $1,950,553,711 +$1,950,553,686 $33.47 74